Creating Awareness: Rothman Orthopaedic Institute Foundation for Opioid Research & Education

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

Rothman Orthopaedic Institute Foundation for Opioid Research was launched by Rothman Orthopaedic Institute, an internationally recognized orthopaedic practice. The news was announced today.

Rothman Orthopaedic Institute Foundation for Opioid Research & Education plans to raise awareness among the medical communities of the risks and benefits of safe opioid use. The non-profit will provide resources to educate patients, physicians, and legislators regarding safe opioid use and other alternatives to pain management.

The foundation will be launching a Facebook Live event at 7:00 PM on July 28th, 2020 in order to interview the foundation’s president, Dr. Asif Ilyas along with Kelly Doyle, CEO of Rothman Orthopaedic Specialty Hospital. The foundation’s president Dr. Ilyas is an award-winning hand and trauma surgeon at Rothman Orthopaedic Institute. During his tenure as President of the Pennsylvania Orthopaedic Society, Dr. Ilyas, led a state-wide movement using evidence-based medicine to review management policies and strategies to find alternatives to opioid use. Doyle has been working in health care for 24 years and recently earned an Executive Masters in Healthcare Leadership from Brown University. She was also recognized as one of Philadelphia Business Journal’s Most Admired CEOs in 2015.

During the upcoming event both Ilyas and Doyle will discuss the foundation and take questions from the public about its goals and objectives.

To participate in the event and submit questions join us on Facebook Live July 28th at 7:00 PM. For more information on how to get involved click here.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles